Ticker
CRVOCompany Name
CERVOMED INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -22.61M | $ -2.53 | 1 | 8.95M |
3/31/2025 | $ -18.67M | $ -2.15 | 1 | 8.7M |
12/31/2024 | $ -16.29M | $ -2.02 | 1 | 8.07M |
9/30/2024 | $ -11.95M | $ -1.37 | 1 | 8.7M |
6/30/2024 | $ -5.04M | $ -0.58 | 1 | 8.7M |
3/31/2024 | $ -4.84M | $ -0.78 | 1 | 6.17M |
12/31/2023 | $ -2.17M | $ -0.82 | 1 | 2.66M |
9/30/2023 | $ -8.13M | $ -2.46 | 1 | 3.31M |
6/30/2023 | $ -13.08M | $ -9.62 | 1 | 1.36M |
3/31/2023 | $ -15.16M | $ -11.15 | 1 | 1.36M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for CERVOMED INC is calculated as follows: EBITDA [ $ -14.71M ] / (Shares WA [ 853.49K ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -17.24 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -11.29 |
max | $ 14.03 |
average | $ 2.03 |
median | $ 1 |
std | $ 4.28 |